Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 78
  1. Jan 06, 2026 · 17:09 · PRN

    Profound sees first Johns Hopkins Tulsa case

    Profound sees first Johns Hopkins Tulsa case

    01
  2. Jan 06, 2026 · 17:01 · VIVI

    TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network

    TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network

    02
  3. Jan 06, 2026 · 16:35 · DRUG

    Bright Minds' BMB-101 phase 2 shows seizure declines

    Bright Minds' BMB-101 phase 2 shows seizure declines

    03
  4. Jan 06, 2026 · 16:00 · DRUG

    Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

    Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

    04
  5. Jan 06, 2026 · 12:32 · LOBE

    Lobe Sciences has cash of $5.85-million at Aug. 31

    Lobe Sciences has cash of $5.85-million at Aug. 31

    05
  6. Jan 06, 2026 · 09:00 · 4875

    2026 New Year's Greetings from the CEO

    2026 New Year's Greetings from the CEO

    06
  7. Jan 06, 2026 · 08:29 · 4543

    Terumo Launches SurTract(TM) Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR(TM) Passive Safety Technology

    Terumo Launches SurTract(TM) Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR(TM) Passive Safety Technology

    07
  8. Jan 06, 2026 · 07:45 · PRN

    Johns Hopkins Medicine Treats First Commercial TULSA-PRO(TM) Case

    Johns Hopkins Medicine Treats First Commercial TULSA-PRO(TM) Case

    08
  9. Jan 06, 2026 · 06:00 · LOBE

    Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

    Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

    09
  10. Jan 05, 2026 · 20:48 · DRUG

    Bright Minds to discuss BMB-101 phase 2 trial Jan. 6

    Bright Minds to discuss BMB-101 phase 2 trial Jan. 6

    10
  11. Jan 05, 2026 · 18:04 · PHRX

    Pharmadrug closes acquisition of 19.9% in Canurta

    Pharmadrug closes acquisition of 19.9% in Canurta

    11
  12. Jan 05, 2026 · 16:21 · HELP

    Cybin starts trading on Nasdaq

    Cybin starts trading on Nasdaq

    12
  13. Jan 05, 2026 · 08:01 · PHRX

    PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

    PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

    13
  14. Jan 02, 2026 · 17:26 · VIVI

    Tempramed reviews 2025, outlines 2026 plans

    Tempramed reviews 2025, outlines 2026 plans

    14
← Newer Older →